화농성 땀샘염에서 경구 항생제와 경구 레티노이드의 치료 효과에 대한 비교 = Comparison of the Efficacy of Systemic Antibiotics and Systemic Retinoids in Hidradenitis Suppurativa

다국어 초록 (Multilingual Abstract)

Background: Hidradenitis suppurativa is a chronic inflammatory skin disease showing recurrent painful nodules and abscesses. Many treatment modalities, such as topical antibiotics, systemic antibiotics, retinoids, immunomodulators, biologics, and surgical treatment are used to treat the disease, but there is no single effective treatment for hidradenitis suppurativa.
Objective: We conducted this study to compare the clinical outcomes of treatment with systemic antibiotics and systemic retinoids.
Methods: We analyzed the clinical features, treatment modalities, and clinical outcomes of patients with hidradenitis suppurativa and compared the clinical outcomes of treatment modalities.
Results: A total of 77 patients were enrolled. Male patients were predominant, and the mean age was 28.1 years. Buttock (42.0%) was the most commonly affected site and 63 patients (81.8%) had lesions at Hurley stage I. Forty-eight patients (62.3%) were treated with systemic antibiotics and 29 (37.7%) with systemic retinoid. Seventy-one patients (92.2%) showed improvement after a mean treatment duration of 8.3 weeks, and 69 (89.6%) experienced recurrence after improvement. Systemic antibiotics showed a relatively high improvement rate, short mean treatment duration, and low recurrence rate compared with systemic retinoids, but the differences were not statistically significant. Among systemic antibiotics, both tetracycline and macrolide showed good therapeutic effects for HS, but the differences were also not statistically significant.
Conclusion: In this study, systemic antibiotics were associated with superior treatment outcomes compared to systemic retinoids, though without statistical significance. In the case of mild lesions, treatment with systemic retinoids appears to show comparable effectiveness to systemic antibiotics. (Korean J Dermatol 2017;55(10):651∼656)

참고문헌 (Reference)

1 Lee RA, "Treatment of hidradenitis suppurativa with biologic medications" 73 (73): S82-S88, 2015

2 Attanoos RL, "The pathogenesis of hidradenitis suppurativa: a closer look at apocrine and apoeccrine glands" 133 : 254-258, 1995

3 Blok JL, "Systemic therapy with immunosuppressive agents and retinoids in hidradenitis suppurativa: a systematic review" 168 : 243-252, 2013

4 Jemec GB, "Sebum excretion in hidradenitis suppurativa" 194 : 325-328, 1997

5 Wolkenstein P, "Quality of life impairment in hidradenitis suppurativa: a study of 61 cases" 56 : 621-623, 2007

6 Nazary M, "Pathogenesis and pharmacotherapy of hidradenitis suppurativa" 672 : 1-8, 2011

7 Ball SL, "Managing patients with hidradenitis suppurativa" 260 : 25-29, 2016

8 Boer J, "Long-term results of isotretinoin in the treatment of 68 patients with hidradenitis suppurativa" 40 : 73-76, 1999

9 Kurokawa I, "Japan Acne Research Society. Questionnaire surveillance of hidradenitis suppurativa in Japan" 42 : 747-749, 2015

10 Jones DH, "Hidradenitis suppurativa—lack of success with 13-cis-retinoic acid [letter]" 107 : 252-, 1982

11 Scheinfeld N., "Hidradenitis suppurativa: A practical review of possible medical treatments based on over 350 hidradenitis patients" 19 : 1-, 2013

12 Brown CF, "Hidradenitis suppurativa of the anogenital region: response to isotretinoin" 158 : 12-15, 1988

13 von Laffert M, "Hidradenitis suppurativa / acne inversa: bilocated epithelial hyperplasia with very different sequelae" 164 : 367-371, 2011

14 Laffert MV, "Hidradenitis suppurativa (acne inversa): early inflammatory events at terminal follicles and at interfollicular epidermis" 19 : 533-537, 2010

15 Revuz J., "Hidradenitis suppurativa" 23 : 985-998, 2009

16 Danby FW, "Hidradenitis suppurativa" 28 : 779-793, 2010

17 Zouboulis CC, "Fitz-patrick’s dermatology in general medicine" Mcgraw-Hill 947-959, 2012

18 Vahlquist A, "Fitz-patrick’s dermatology in general medicine" Mcgraw-Hill 2759-2762, 2012

19 Norris JFB, "Failure of treatment of familial widespread hidradenitis suppurativa with isotretinoin" 11 : 579-583, 1986

20 Dicken CH, "Evaluation of isotretinoin treatment of hidradenitis suppurativa" 11 : 500-502, 1984

21 Hayashi N, "Efficacy of oral antibiotics on acne vulgaris and their effects on quality of life: a multicenter randomized controlled trial using minocycline, roxithromycin and faropenem" 38 : 111-119, 2011

22 Kobayashi M, "Effects of oral antibiotic roxithromycin on quality of life in acne patients" 36 : 383-391, 2009

23 Boer J., "Dermatology in five continents, World Congress of Dermatology" Springer Verlag 1152-1153, 1988

24 Hurley H, "Dermatologic surgery:principles and practice" Marcel Dekker 729-739, 1989

25 최미영, "Comparative efficacy of biological agents in methotrexate- refractory rheumatoid arthritis patients: a Bayesian mixed treatment comparison" 대한내과학회 32 (32): 536-547, 2017

26 Canoui-Poitrine F, "Clinical characteristics of a series of 302 French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severity" 61 : 51-57, 2009

27 Soria A, "Absence of efficacy of oral isotretinoin in hidradenitis suppurativa:a retrospective study based on patients’ outcome assessment" 218 : 134-135, 2009